Harikrishnareddy Paluvai
Udine, 33100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Histone deacetylase (HDACs) inhibitors: Clinical applications.
Journal: Progress in molecular biology and translational science
Published: May 24, 2023
HDAC4 influences the DNA damage response and counteracts senescence by assembling with HDAC1/HDAC2 to control H2BK120 acetylation and homology-directed repair.
Journal: Nucleic acids research
Published: May 11, 2023
Insights into the function of HDAC3 and NCoR1/NCoR2 co-repressor complex in metabolic diseases.
Journal: Frontiers in molecular biosciences
Published: March 20, 2023
HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers.
Journal: Genome biology
Published: October 29, 2020
Genetic Programs Driving Oncogenic Transformation: Lessons from in Vitro Models.
Journal: International journal of molecular sciences
Published: October 30, 2019
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells.
Journal: Nucleic acids research
Published: June 13, 2019
Unscheduled HDAC4 repressive activity in human fibroblasts triggers TP53-dependent senescence and favors cell transformation.
Journal: Molecular oncology
Published: June 14, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026